Carclo PLC
Carclo PLC is a chemical manufacturing company that produces commodity chemicals, primarily generating revenue through the sale of chemical products to industrial and commercial customers.
Business. Carclo PLC (C1Y.L) is a chemicals company operating within the commodity chemicals industry. The firm is headquartered in the United Kingdom and is primarily listed on the London Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Carclo PLC (C1Y.L) is a chemicals company operating within the commodity chemicals industry. The firm is headquartered in the United Kingdom and is primarily listed on the London Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Carclo PLC operates with a negative equity position of £11.8 million and a debt-to-equity ratio of -2.54, indicating a highly leveraged capital structure. The company's liquidity position is assessed as medium, with a current ratio of 0.79, suggesting limited short-term liquidity to cover immediate liabilities. Free cash flow stands at £6.3 million, which is lower than operating cash flow of £11.5 million, reflecting capital expenditures of £1.1 million in the period.
Profitability metrics show a return on assets of 0.9%, but a negative return on equity of -7.38%, indicating that the company is not generating returns for shareholders despite maintaining a gross profit margin of 57.1%. This underperformance is below the typical expectations for the Commodity Chemicals industry, where ROE and ROA are generally higher due to the capital-intensive nature of the sector.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financial data. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes, particularly in the UK, where the company is headquartered.
Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or contraction projected in the current or next fiscal year. However, the absence of disclosed capital expenditure plans beyond the £1.1 million in the latest period suggests limited investment in future growth or operational expansion.
The risk assessment highlights a key flag: the company has negative net cash after subtracting total debt, which could constrain its ability to fund operations or respond to unexpected financial pressures. While dilution risk is currently assessed as low, the negative equity position and high leverage could increase the likelihood of equity issuance in the future, particularly if the company requires additional capital to service debt or fund operations.
Recent filings and transcripts do not indicate any material events or strategic shifts in the company's operations or financial strategy. Analysts have issued a strong buy recommendation, with a mean price target of £90.00, but the consensus is based on a single strong buy rating, suggesting limited analyst coverage or confidence in the stock's performance.
- Carclo PLC is highly leveraged with a negative equity position and a debt-to-equity ratio of -2.54.
- The company's return on equity is negative at -7.38%, indicating poor shareholder returns.
- Revenue is concentrated in a single business segment with no geographic diversification disclosed.
- Analysts have issued a strong buy recommendation, but the consensus is based on a single analyst.
- The company's liquidity position is medium, with a current ratio of 0.79 and negative net cash after debt.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,04 |
| Revenue | —no estimate | —no estimate | 114,4M GBP |
| Operating income | —no estimate | —no estimate | 12,1M GBP |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Carclo PLC Market data — financials · 2026-05-27
- Carclo PLC Market data — analyst estimates · 2026-05-27
Ownership & reference
Leadership
- Frank DoorenboschChief Executive Officer, Executive Director